Webinar | July 10, 2020

Beyond Brexit: What Now For Clinical Supply Across Europe?

Source: Catalent

After 3 years of Brexit withdrawal negotiations, the UK is officially no longer a member of the European Union. Clinical sponsors with active and planned studies in the EU and UK can be reassured that the UK will remain part of the current trade arrangements, customs union and single market until the end of the transition period on December 31, 2020. Although future change is certain after the transition period ends, clinical sponsors now have a clearer vision of what strategic options are available so that they may continue to run trials in the UK and EU. This panel presentation will explore the early analysis of potential Brexit challenges that sponsors face and the strategic solutions that can support sponsors in a post-Brexit world.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: